Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer
Utu:T/T, L/C
Takenga Hua:Haina
Tauranga Tukunga:Beijing/Shanghai/Hangzhou
Te kaha whakaputa:100kg/marama
Raupapa(MOQ):25kg
Wā Arataki:3 Nga Ra Mahi
Tikanga rokiroki:Whakaorangia ki te waahi makariri, maroke, te pāmahana rūma.
rauemi mōkihi:pahū
Rahi mōkihi:25kg/pahū
Nga korero haumaru:Ehara i nga taonga kino
Kupu Whakataki
Ko te Tofacitinib, he rongoa e whakamahia ana ki te rongoa i te mate rūmātiki, te mate pukupuku psoriatic, me te ulcerative colitis.
Ka whakamahia te Tofacitinib citrate ki te rongoa i nga pakeke e mate ana i te mate rumati rūmātiki tino kaha ki te kore e tika te whakautu ki te methotrexate.
Ko te Tofacitinib citrate e tohuhia ana mo te maimoatanga o te ngawari ki te kaha o te mate rūmātiki (RA) i roto i nga pakeke kaore i te pai te whakautu ki a ratau, kaore ranei e aro ki tetahi, neke atu ranei nga raau taero antirheumatic.
Whakatakotoranga (i roto i te whare)
| Tūemi | Whakatakotoranga |
| Te ahua | Te paura tioata ma, he ma ranei |
| Tautuhinga | IR, HPLC |
| Wai | ≤1.5% |
| Nga Taonga Paanga | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib dehydrogenated ≤0.15% | |
| Ia poke unknown ≤0.10% | |
| Tapeke Whakakore: ≤1.0% | |
| Wairewa toenga | Ewaro ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N,N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Te pungarehu ngongo | ≤0.1% |
| Kounga Taumaha | ≤10ppm |
| HPLC Chria | 3S, 4S tofacitinib ≤0.15% |
| Whakamātautau (i runga i te tikanga kore wai) 98.0-102.0% |
